Researchers have identified a genetic blueprint that could make it easier to produce rare medicinal compounds found in two highly toxic flowering plants. Although these plants can trigger neurotoxicity and paralysis in extremely small amounts, the same chemical families have drawn attention for their potential use against pain, malaria, cancer and agricultural pests.
According to the report, the advance marks the first time scientists have uncovered a workable path to recreating these hard-to-synthesize compounds in the lab. That matters because many plant-made molecules are chemically complex, which has made them difficult to study, reproduce and adapt for wider medical or commercial use.
By tracing how the plants build these potent substances, researchers created a roadmap for laboratory production rather than relying only on harvesting small amounts from dangerous natural sources. A lab-based approach could also help scientists test variations of the compounds and better understand which parts of the molecules are responsible for both their benefits and their toxic effects.
The finding could support future work on safer medicines and other useful products derived from these powerful plant chemicals. While more research is still needed before any practical applications emerge, the study offers a clearer route for turning deadly natural compounds into tools that may be more accessible for drug development and other uses.
